胸骨后甲状腺肿被误判为高功能性转移灶:一例治疗后131I SPECT/CT病例
一例38岁男性甲状腺乳头状癌患者行全甲状腺切除及右颈根治性清扫后接受131I治疗。停用左甲状腺素4周后处于亚临床甲状腺功能减退状态,刺激后Tg水平显著升高,提示高功能性转移。治疗后第3天131I全身扫描联合SPECT/CT显示颈胸区域一高摄取肿块,但组织学证实为胸骨后甲状腺肿。
要点
- 甲状腺癌术后131I治疗后SPECT/CT高摄取灶需鉴别胸骨后甲状腺肿。
- 刺激后Tg显著升高提示高功能性转移,但组织学可排除。
- 胸骨后甲状腺肿可模拟高功能性转移灶,需组织病理确诊。
核心结论
- 胸骨后甲状腺肿可在治疗后131I SPECT/CT上表现为高摄取肿块,被误判为高功能性转移灶。
研究设计与样本
- 个案报道:一例38岁男性甲状腺乳头状癌患者,行全甲状腺切除及右颈根治性清扫后接受131I治疗。
主要发现
- 患者停用左甲状腺素4周后处于亚临床甲状腺功能减退状态,刺激后Tg水平显著升高。
- 治疗后第3天131I全身扫描联合SPECT/CT显示颈胸区域一高摄取肿块。
- 该肿块经组织学证实为胸骨后甲状腺肿。
临床怎么用
- 甲状腺癌术后131I治疗后SPECT/CT发现颈胸区域高摄取灶时,应鉴别胸骨后甲状腺肿,避免误判为转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present a 38-year-old man who underwent total thyroidectomy with radical right neck dissection due to papillary thyroid cancer was referred for 131I treatment. The patient was in subclinical hypothyroidism with remarkable stimulated Tg level after 4 weeks of l-thyroxine withdrawal before 131I treatment, which indicated hyperfunctioning metastasis. Posttherapeutic 131I whole-body scan combined with 131I SPECT/CT performed on day 3 after 131I administration revealed an elevated 131I uptake mass in cervicothoracic region. To our surprise, the mass was histologically confirmed to be a retrosternal goiter.
引用
- Hou LY, Luo QY, Qiu ZL, et al. Unexpected Retrosternal Goiter Interpreted as Hyperfunctioning Metastasis on the Posttherapeutic 131I SPECT/CT. Clin Nucl Med. 2022. PMID: 34661561. doi:10.1097/RLU.0000000000003908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。